2025 annual financial data
Unicycive Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -29,517,000 USD and net income was -26,555,000 USD.
Operating cash flow was -31,317,000 USD.
Get free Unicycive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -29,517,000 USD
- Net income
- -26,555,000 USD
- Operating cash flow
- -31,317,000 USD